Aditxt Inc. (ADTX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Aditxt Inc. (ADTX:NASDAQ), powered by AI.

Current Price
$0.01
Sector
Healthcare
What is the Aditxt Inc. stock price forecast?

Aditxt Inc. is currently trading at $0.01. View real-time AI analysis on Alpha Lenz.

What is Aditxt Inc. insider trading activity?

View the latest insider trading data for Aditxt Inc. on Alpha Lenz.

What is Aditxt Inc.'s P/E ratio?

View Aditxt Inc.'s valuation metrics on Alpha Lenz.

Aditxt Inc.

NASDAQ · ADTX
$0.01+0.01(+150.00%)LiveNASDAQ regular session 09:30–16:00 ET
Ask about Aditxt Inc.'s future dividend policy...
Alpha Chat Insight

Aditxt Inc.'s ROE is -576.2%. Explore profitability and growth together.

Ask for details

Company Overview

Aditxt Inc. is a biotechnology company focused on developing technologies that improve the health of the immune system. Its primary purpose is to enhance immune monitoring and reprogramming techniques, which are pivotal in managing diseases and improving the quality of life. The company is involved in creating innovative solutions that can help prevent and treat allergies, viruses, and a variety of immune system-related conditions. Aditxt’s research and technology have significant implications across several sectors, notably in the fields of personalized medicine and infectious diseases. By emphasizing a deeper understanding of the immune system and its dynamics, Aditxt aims to revolutionize approaches to both immune monitoring and therapeutic intervention. In the biotechnology and healthcare markets, its advancements contribute to the growing demand for personalized and precise medical treatments, showcasing its pivotal role in the next generation of medical biotechnology.

CEOMr. Amro A. Albanna
SectorHealthcare
IndustryBiotechnology
Employees26

Company Statistics

FY 2025

Profile

N/AMarket Cap
$3.19KRevenue
0.00Shares Out
26Employees

Margins

8.39%Gross
-597744.63%EBITDA
-612542.22%Operating
-1339187.57%Pre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-84.93%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-175.86%ROA
-576.19%ROE
-166.04%ROIC

Financial Health

$3.20MCash & Cash Equivalents
$9.36MNet Debt
317.76%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Aditxt Inc. (ticker: ADTX) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 26 employees.

The current price is $0.01 with a P/E ratio of -x and P/B of -x.

ROE is -576.19% and operating margin is -612542.22%. Annual revenue is $3,195.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Aditxt Inc. (ADTX) Stock Forecast 2026 $0.01 — Price, Financials & Analyst Targets | Alpha Lenz